tiprankstipranks
3 Best Stocks to Buy Now, 8/13/2024, According to Top Analysts 
Market News

3 Best Stocks to Buy Now, 8/13/2024, According to Top Analysts 

Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new Buy rating recently and has a significant upside as well.

Pick the best stocks and maximize your portfolio:

To find more stocks like these, take a look at TipRanks’ Analyst Top Stocks tool. It shows you a real-time list of all stocks that have been recently rated by Top-ranking Analysts. 

Here are today’s top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. 

Stereotaxis (STXS) – This medical technology company provides robotic systems for minimally invasive surgery, particularly in cardiovascular procedures. Today, TD Cowen analyst Josh Jennings maintained a Buy rating on the stock with a $5 price target. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Altogether, their 12-month price targets imply an upside of over 159%.

Skyward Specialty Insurance Group (SKWD) – This specialty insurance company offers tailored insurance solutions for niche markets. Today, JMP Securities analyst Matthew Carletti reiterated a Buy rating on the stock with a price target of $50. In the last three months, five out of the six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of over 33%.

Inozyme Pharma (INZY) – INZY is a clinical-stage biopharmaceutical company that develops treatments for rare diseases that impact the soft tissues and skeleton. Today, Jefferies analyst Maury Raycroft reiterated a Buy rating on the stock with a price target of $17. In the last three months, all three Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of nearly 430%.

Who are the Top Analysts? 

TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. 

See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks’ Top Wall Street Analysts page. 

Disclosure 

Related Articles
TheFlyInozyme initiated with an Outperform at Raymond James
TipRanks Auto-Generated NewsdeskInozyme Pharma’s Q3 2024 Financial and Clinical Progress
TheFlyInozyme reports Q3 EPS (39c), consensus (44c)
Go Ad-Free with Our App